Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29)

V Gross1, T Andus, R Daig

  • 1First Department of Internal Medicine, University of Regensburg, Germany.

Gastroenterology
|March 1, 1995
PubMed

Insights

Interleukin-8 (IL-8) synthesis in intestinal cells is induced by IL-1 beta and TNF-alpha. This process relies on protein tyrosine kinase (PTK) activity, not protein kinase C (PKC) or protein kinase A (PKA).

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Interleukin-8 (IL-8) is a key cytokine produced by intestinal epithelial cells that activates neutrophils.
  • Understanding the regulation of IL-8 synthesis is crucial for inflammatory bowel disease research.

Purpose of the Study:

  • To investigate the roles of protein kinase C (PKC), protein kinase A (PKA), and protein tyrosine kinase (PTK) in regulating IL-8 synthesis.
  • To elucidate the signaling pathways involved in IL-8 induction by IL-1 beta and TNF-alpha in intestinal cells.

Main Methods:

  • HT-29 intestinal cells were stimulated with IL-1 beta or TNF-alpha.
  • Activators/inhibitors of PKC and PKA, and PTK inhibitors were used.
  • IL-8 protein and messenger RNA levels were quantified using ELISA, Northern blotting, and in situ hybridization.

Main Results:

  • IL-1 beta and TNF-alpha dose-dependently increased IL-8 production.
  • PKC activation stimulated IL-8, but IL-1 beta/TNF-alpha induction was PKC-independent.
  • PKA modulation had no effect on IL-8 synthesis.
  • PTK inhibitors significantly reduced IL-8 induction by IL-1 beta and TNF-alpha.

Conclusions:

  • IL-8 synthesis in HT-29 cells is stimulated by IL-1 beta and TNF-alpha.
  • This induction is independent of PKC and PKA signaling pathways.
  • Protein tyrosine phosphorylation is essential for IL-8 induction.
Abstract

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K